.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Expert Review on the Multidisciplinary Management of Bladder Cancer

EP. 1: Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

March 27th 2015

EP. 2: Lymph Node Dissection in Bladder Cancer

March 27th 2015

EP. 3: Managing Renal Pelvis Transitional Cell Carcinoma

March 27th 2015

EP. 4: Neoadjuvant and Adjuvant Therapy in Bladder Cancer

March 27th 2015

EP. 5: Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

March 27th 2015

EP. 6: Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015

EP. 7: Treating Relapsed Muscle-Invasive Bladder Cancer

March 27th 2015

EP. 8: Potential Targets in Muscle-Invasive Bladder Cancer

March 27th 2015

EP. 9: Anti-PD-L1 Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015

EP. 10: Novel Therapies Needed for Muscle-Invasive Bladder Cancer

March 27th 2015